Biofeedback fixation training method for improving eccentric vision in patients with loss of foveal function secondary to different maculopathies.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 07 05 2019
accepted: 19 09 2019
pubmed: 5 10 2019
medline: 8 1 2021
entrez: 5 10 2019
Statut: ppublish

Résumé

Fixation stability (FS) of the preferred retinal locus (PRL) may be improved by biofeedback fixation training (BFT) with microperimetry. Such training can be done on the patient's PRL or in different retinal loci with better functional characteristics. We studied both options and compared the outcomes. Sixty-seven consecutive patients with bilateral central vision loss, poor FS and visual acuity (VA) lower than 0.3 LogMAR were recruited for BFT with microperimeter. Patients were assigned into 2 groups. In group A, BFT was performed on the patient's spontaneous PRL. In group B, PRL was located between 2 adjacent loci with the highest light sensitivity and the lowest distance from the fovea. Two sets of 12 weekly BFT sessions were performed. Primary outcomes were: FS, VA and reading speed. Outcomes were statistically significantly better in group B. Mean percentage of FS at therapy end improved from 32 to 35% for group A and from 40 to 55% in group B. Mean VA improved from 1 to 0.86 in group A and from 1 to 0.84 in group B. Reading speed (wpm) improved from 56 to 58 in group A and from 63 to 89 in group B. This study describes a reliable methodology of improving eccentric fixation stability using BFT in microperimetry, when the fixation training locus is individualized as the retinal area with best functional characteristics. Further studies are needed to validate its value in a larger scale of patients, at different stages of the disease, and its persistence over time.

Identifiants

pubmed: 31583549
doi: 10.1007/s10792-019-01180-y
pii: 10.1007/s10792-019-01180-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-312

Références

J Ophthalmol. 2015;2015:572942
pubmed: 26783452
Int J Retina Vitreous. 2017 May 22;3:21
pubmed: 28536656
Funct Neurol. 2013 Oct-Dec;28(4):285-91
pubmed: 24598397
Invest Ophthalmol Vis Sci. 2011 Feb 28;52(2):1164-70
pubmed: 21087972
BMC Ophthalmol. 2006 Nov 23;6:35
pubmed: 17123448
Retina. 2011 Nov;31(10):2109-14
pubmed: 21555970
Can J Ophthalmol. 2013 Oct;48(5):368-74
pubmed: 24093182
Can J Ophthalmol. 2013 Oct;48(5):431-7
pubmed: 24093192
NeuroRehabilitation. 2018;42(2):167-172
pubmed: 29562553
Can J Ophthalmol. 2006 Jun;41(3):289-312
pubmed: 16767184
Clin Exp Optom. 2019 Mar;102(2):172-179
pubmed: 30253443
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):84-9
pubmed: 18757517
Vis Neurosci. 2009 Nov;26(5-6):487-94
pubmed: 20003597
Curr Opin Neurol. 2015 Dec;28(6):549-55
pubmed: 26402404
Ophthalmology. 2002 Sep;109(9):1737-44
pubmed: 12208725
Ophthalmic Physiol Opt. 2013 Jul;33(4):516-26
pubmed: 23550537
Appl Psychophysiol Biofeedback. 2007 Dec;32(3-4):185-9
pubmed: 17574525
Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5452-61
pubmed: 22661485
BMJ Case Rep. 2015 Jan 09;2015:
pubmed: 25576513
Transl Vis Sci Technol. 2016 Nov 15;5(6):6
pubmed: 27867756
Curr Opin Neurobiol. 2005 Apr;15(2):161-7
pubmed: 15831397
Ophthalmology. 1997 Apr;104(4):632-8
pubmed: 9111255
Front Hum Neurosci. 2013 Dec 24;7:887
pubmed: 24399951
Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7376-84
pubmed: 21724911
Acta Ophthalmol Scand. 2007 Dec;85(8):868-70
pubmed: 17651472
Vision Res. 2003 Jul;43(16):1777-87
pubmed: 12818347
Eur J Ophthalmol. 2013 Sep-Oct;23(5):723-31
pubmed: 23640508

Auteurs

Marco U Morales (MU)

Academic Ophthalmology, Division of Clinical Neurosciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK. marcoulisesmorales@gmail.com.

Saker Saker (S)

Academic Ophthalmology, Division of Clinical Neurosciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.

Craig Wilde (C)

Academic Ophthalmology, Division of Clinical Neurosciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.

Martin Rubinstein (M)

Department of Optometry, University of Leicester, Leicester Royal Infirmary, Leicester, UK.

Paolo Limoli (P)

Centro Studi Ipovisione, Milan, Italy.

Winfried M Amoaku (WM)

Academic Ophthalmology, Division of Clinical Neurosciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH